We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sekisui Xenotech Add Human And Minipig Fractions To Testing Capability

Product News   Feb 02, 2017 | Original Story from Sekisui Xenotech

 
Sekisui Xenotech Add Human And Minipig Fractions To Testing Capability
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Microfluidizer Offers Effective Cell Disruption

Product News

Analytik reports on how the School of Biological & Chemical Sciences at Queen Mary University, London (QMUL) has been using a LM20 Microfluidizer for cell disruption of a broad range of cell types including E. coli, Yeasts and Diatom.

READ MORE

Thermo Fisher Scientific Announces Launch of Lentivirus Production Solution Aimed to Produce High Titer Lentiviral Vectors

Product News

High-titer lentiviral vector production in a scalable suspension culture system format for use in cell and gene therapy applications.

READ MORE

KBL Merger Corp. IV SPAC Announces Non-Binding Term Sheet to Acquire CannBioRx Life Sciences Corp. and its Three Interactive Programs

Product News

Programs focused on developing novel pharmaceutical drugs and man-made cannabinoids that target Key pathways in inflammatory diseases.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE